Cahill Gordon & Reindel

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
Cases30
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechMech Eng, ManufChemical
Elite Ratings
DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered
Case
Description
09/03/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (jaa) (Entered: 09/03/2024)
09/03/24
SO ORDERED, re 79 Stipulation and Order of Dismissal Without Prejudice. ***Civil Case Terminated.. Signed by Judge Gregory B. Williams on 9/3/24. (jaa) (Entered: 09/03/2024)
07/12/24
SUR-REPLY to Reply to Response to Motion re 44 MOTION to Dismiss 32 Amended Complaint filed by Intercurrency Software LLC. (Honea, Christopher) (Entered: 07/12/2024)
01/17/24
REQUEST FOR ISSUANCE OF SUMMONS as to MaryLou Talafous-Favetta, re: 1 Complaint,. Document filed by CarbonCharge Technologies LLC..(Kurtzberg, Joel) (Entered: 01/17/2024)
01/17/24
CIVIL COVER SHEET filed..(Kurtzberg, Joel) (Entered: 01/17/2024)
01/17/24
COMPLAINT against MaryLou Talafous-Favetta. (Filing Fee $ 405.00, Receipt Number ANYSDC-28823098)Document filed by CarbonCharge Technologies LLC. (Attachments: # 1 Exhibit 1: Last Will and Testament, # 2 Exhibit 2: '324 Patent, # 3 Exhibit 3: '563 Patent, # 4 Exhibit 4: Assignments from Messrs. Rosse and Slattery, # 5 Exhibit 5: '324 Patent Prosecution History, # 6 Exhibit 6: '563 Patent Prosecution History).(Kurtzberg, Joel) (Entered: 01/17/2024)
09/05/23
Final Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,749,532 B2; 8,206,740 B2. (twk) (Entered: 09/05/2023)
09/05/23
SO ORDERED, re 13 STIPULATION of Dismissal Without Prejudice. (CASE CLOSED). Signed by Judge Stephanos Bibas on 9/5/2023. (twk) (Entered: 09/05/2023)
12/03/21
Summons Issued with Magistrate Consent Notice attached as to Lupin Inc. on 12/3/2021; Lupin Limited on 12/3/2021. (Attachments: # 1 Summons Issued)(apk) (Entered: 12/03/2021)
12/03/21
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Drug Royalty III LP 2, Corporate Parent DRI Healthcare Trust for TCD Royalty Sub LP; Corporate Parent Galderma Services Inc. for Galderma Laboratories L.P. filed by Galderma Laboratories L.P., TCD Royalty Sub LP. (apk) (Entered: 12/03/2021)